S. 4591

S. 4591: NO FAKES Act of 2026

Reported by Committee Christopher Coons (D) SENATE_BILL — 119th Congress
Plain English Summary

The NO FAKES Act of 2026 aims to combat the production and distribution of counterfeit goods in the United States. It likely includes measures to strengthen enforcement against counterfeit products, enhance penalties for offenders, and provide resources for businesses affected by counterfeit operations.

Positive Media Summary

Media outlets have praised the NO FAKES Act of 2026 for its proactive approach to addressing the growing issue of counterfeit goods, highlighting its potential to protect consumers and support legitimate businesses. Advocates believe the bill will help preserve brand integrity and promote fair competition in the marketplace.

Negative Media Summary

Critics of the NO FAKES Act of 2026 have raised concerns about the potential overreach of enforcement measures, arguing that the bill could lead to excessive regulation and unintended consequences for small businesses. Some fear it may disproportionately affect certain industries or stifle innovation in the marketplace.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$1,365,000,000
PAC Percentage
0%
Policy Area
Commerce

The NO FAKES Act of 2026, sponsored by Christopher Coons, does not show any direct industry overlaps with the sponsor's top donor industries, which include Health Professionals and Retired individuals. The absence of direct connections suggests that the financial interests of the top donors are unlikely to influence the bill's provisions. Furthermore, the lobbying activity in the relevant policy area does not indicate significant financial backing from industries that would directly benefit from the bill, as most amounts are undisclosed or relatively low, with only $132,500 reported from identifiable sources. This indicates a low risk of conflicts of interest related to the sponsor's financial backers.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
SPRAY FOAM COALITION SPRAY FOAM COALITION $60,000
SHANDA ASSET MANAGEMENT LLC SHANDA ASSET MANAGEMENT LLC $50,000
GREEN OCEANS EDNEXUS ADVISORS, LLC $22,500
JOHN BRIAN LEDBETTER MISSIONS JOHN BRIAN LEDBETTER MISSIONS CORPORATION undisclosed
JOHN BRIAN LEDBETTER MISSIONS CORPORATION JOHN BRIAN LEDBETTER MISSIONS CORPORATION undisclosed
LG ELECTRONICS USA, INC. HOLLAND & KNIGHT LLP undisclosed
RIDE GROUP LLC AKIN GUMP STRAUSS HAUER & FELD undisclosed
CRESCENTA VALLEY WATER DISTRICT CAPITOL CORE GROUP, INC. undisclosed
ALIBABA GROUP HOLDING LIMITED SIDLEY AUSTIN LLP undisclosed
SPACECONNECT ASSOCIATION SALT POINT STRATEGIES undisclosed
CURIUM US LLC CORNERSTONE GOVERNMENT AFFAIRS, INC. undisclosed
TWINZA OIL LIMITED ANCHOR GROUP LLC undisclosed
PUBLIC PRIVATE STRATEGIES VALENTINE STRATEGIES undisclosed
PELICAN ENERGY PARTNERS LP CORNERSTONE GOVERNMENT AFFAIRS, INC. undisclosed
CORVUS CONSTRUCTION COMPANY, INC. CORNERSTONE GOVERNMENT AFFAIRS, INC. undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Christopher Coons, ranked by total contributions.

Health Professionals $1,040,000,000
Individuals: $1,040,000,000 PACs: $0
Retired $325,000,000
Individuals: $325,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us